Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George P Kim

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 10, 2010
Report of a multicenter phase II trial testing a combination of biweekly bevacizumab and daily erlotinib in patients with unresectable biliary cancer: a phase II Consortium studySam J Lubner, Michelle R Mahoney, Jill L Kolesar, et al.
Cancer|May 25, 2005
Evaluation of shark cartilage in patients with advanced cancer: a North Central Cancer Treatment Group trialCharles L Loprinzi, Ralph Levitt, Debra L Barton, et al.
Pancreas|March 14, 2014
Should combination chemotherapy serve as the backbone in clinical trials of advanced pancreatic cancer? A pooled analysis of phase II trials of gemcitabine-containing doublets plus bevacizumabKatherine Van Loon, Anne M Espinoza, David R Fogelman, et al.
Endocrine-Related Cancer|September 13, 2023
A phase II study of bevacizumab and temsirolimus in advanced extra-pancreatic neuroendocrine tumorsSonia M Abuzakhm, Vineeth Sukrithan, Briant Fruth, et al.
Journal of Oncology Practice|April 17, 2014
Changes in the care of non-small-cell lung cancer after audit and feedback: the Florida initiative for quality cancer careTawee Tanvetyanon, Ji-Hyun Lee, William J Fulp, et al.
Journal of Oncology Practice|May 21, 2015
Use of Adjuvant Cisplatin-Based Versus Carboplatin-Based Chemotherapy in Non-Small-Cell Lung Cancer: Findings From the Florida Initiative for Quality Cancer CareTawee Tanvetyanon, Ji-Hyun Lee, William J Fulp, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 2017
A Randomized, Double-Blind, Placebo-Controlled Phase II Study of the Efficacy and Safety of Monotherapy Ontuxizumab (MORAb-004) Plus Best Supportive Care in Patients with Chemorefractory Metastatic Colorectal CancerAxel Grothey, Jonathan R Strosberg, Lindsay A Renfro, et al.
Brachytherapy|August 20, 2013
Complications after 90Y microsphere radioembolization for unresectable hepatic tumors: An evaluation of 112 patientsJennifer L Peterson, Laura A Vallow, Douglas W Johnson, et al.
Molecular Cancer Therapeutics|January 30, 2016
Phase I Study of DMOT4039A, an Antibody-Drug Conjugate Targeting Mesothelin, in Patients with Unresectable Pancreatic or Platinum-Resistant Ovarian CancerColin D Weekes, Laetitia E Lamberts, Mitesh J Borad, et al.
Journal of Oncology Practice|March 2, 2012
Quality of care in non-small-cell lung cancer: findings from 11 oncology practices in FloridaTawee Tanvetyanon, Michelle Corman, Ji-Hyun Lee, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 10, 2010
Report of a multicenter phase II trial testing a combination of biweekly bevacizumab and daily erlotinib in patients with unresectable biliary cancer: a phase II Consortium studySam J Lubner, Michelle R Mahoney, Jill L Kolesar, et al.
Cancer|May 25, 2005
Evaluation of shark cartilage in patients with advanced cancer: a North Central Cancer Treatment Group trialCharles L Loprinzi, Ralph Levitt, Debra L Barton, et al.
Pancreas|March 14, 2014
Should combination chemotherapy serve as the backbone in clinical trials of advanced pancreatic cancer? A pooled analysis of phase II trials of gemcitabine-containing doublets plus bevacizumabKatherine Van Loon, Anne M Espinoza, David R Fogelman, et al.
Endocrine-Related Cancer|September 13, 2023
A phase II study of bevacizumab and temsirolimus in advanced extra-pancreatic neuroendocrine tumorsSonia M Abuzakhm, Vineeth Sukrithan, Briant Fruth, et al.
Journal of Oncology Practice|April 17, 2014
Changes in the care of non-small-cell lung cancer after audit and feedback: the Florida initiative for quality cancer careTawee Tanvetyanon, Ji-Hyun Lee, William J Fulp, et al.
Journal of Oncology Practice|May 21, 2015
Use of Adjuvant Cisplatin-Based Versus Carboplatin-Based Chemotherapy in Non-Small-Cell Lung Cancer: Findings From the Florida Initiative for Quality Cancer CareTawee Tanvetyanon, Ji-Hyun Lee, William J Fulp, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 2017
A Randomized, Double-Blind, Placebo-Controlled Phase II Study of the Efficacy and Safety of Monotherapy Ontuxizumab (MORAb-004) Plus Best Supportive Care in Patients with Chemorefractory Metastatic Colorectal CancerAxel Grothey, Jonathan R Strosberg, Lindsay A Renfro, et al.
Brachytherapy|August 20, 2013
Complications after 90Y microsphere radioembolization for unresectable hepatic tumors: An evaluation of 112 patientsJennifer L Peterson, Laura A Vallow, Douglas W Johnson, et al.
Molecular Cancer Therapeutics|January 30, 2016
Phase I Study of DMOT4039A, an Antibody-Drug Conjugate Targeting Mesothelin, in Patients with Unresectable Pancreatic or Platinum-Resistant Ovarian CancerColin D Weekes, Laetitia E Lamberts, Mitesh J Borad, et al.
Journal of Oncology Practice|March 2, 2012
Quality of care in non-small-cell lung cancer: findings from 11 oncology practices in FloridaTawee Tanvetyanon, Michelle Corman, Ji-Hyun Lee, et al.
Pageof 5